Drug Guidance for Subsidy 04/06/2024 Prostaglandin analogue with timolol fixed-dose combination eye drops for treatment of open-angle glaucoma or ocular hypertension The Ministry of Health’s Drug Advisory Committee has recommended: Latanoprost/timolol 0.005%/... See all × 04/06/2024 Prostaglandin analogue with timolol fixed-dose combination eye drops for treatment of open-angle glaucoma or ocular hypertension The Ministry of Health’s Drug Advisory Committee has recommended: Latanoprost/timolol 0.005%/0.5% eye drops in line with its registered indication for reducing intraocular pressure in patients with open-angle glaucoma and ocular hypertension, in view of acceptable price proposal from the manufacturer. Subsidy status RLatanoprost/timolol 0.005%/0.5% eye drops is recommended for inclusion on the MOH Standard Drug List (SDL) for the abovementioned indication. NRSDL subsidy does not apply to: bimatoprost/timolol 0.03%/0.5% eye drops; tafluprost/timolol 0.0015%/0.5% eye drops; and travoprost/timolol 0.004%/0.05% eye drops in view of unacceptable price proposals from the manufacturers.
General Availability in Public Healthcare Institution Users are to consult the respective PHIs for actual inventory availability and supply restrictions/consideration Ophthalmic Solution, Sterile, Tafluprost 0.015 mg/mL + Timolol 5 mg/mL Changi General Hospital Khoo Teck Puat Hospital National University Hospital Singapore National Eye Centre Tan Tock Seng Hospital Woodlands Health Campus